Exploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
Exploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
How Neuromodulators Can Treat Functional GI Disorders
How Neuromodulators Can Treat Functional GI Disorders
Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease
Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease
Research Efforts in the Race to Find a Cure for COVID-19
Research Efforts in the Race to Find a Cure for COVID-19
Investigating the Circulation of Counterfeit COVID-19 Medications
Investigating the Circulation of Counterfeit COVID-19 Medications
2020 Crohn’s & Colitis Congress: How & When to Perform Disease & Drug Monitoring
2020 Crohn’s & Colitis Congress: How & When to Perform Disease & Drug Monitoring
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
Off-Label Medicines in Fighting COVID-19 & Through the Years
Off-Label Medicines in Fighting COVID-19 & Through the Years
Uncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
Uncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
REMS-Required Drug Monitoring During the COVID-19 Pandemic
REMS-Required Drug Monitoring During the COVID-19 Pandemic
CDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
CDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
COVID-19 & the Potential for Prescription Drug Shortages
COVID-19 & the Potential for Prescription Drug Shortages
Update on Remdesivir, Investigational Antiviral for COVID-19
Update on Remdesivir, Investigational Antiviral for COVID-19
Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?
Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?